Cargando…

Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma

SMYD2 is a histone methyltransferase that has been reported to be an important epigenetic regulator. This study aims to investigate SMYD2 as a prognostic indicator of clear cell renal cell carcinoma (ccRCC) and explore its role in tumorigenesis and multi-drug resistance. Methods: Tumor specimens, cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Libin, Ding, Beichen, Liu, Haoran, Zhang, Yangjun, Zeng, Jin, Hu, Junhui, Yao, Weimin, Yu, Gan, An, Ruihua, Chen, Zhiqiang, Ye, Zhangqun, Xing, Jinchun, Xiao, Kefeng, Wu, Lily, Xu, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857066/ https://www.ncbi.nlm.nih.gov/pubmed/31754403 http://dx.doi.org/10.7150/thno.37628

Ejemplares similares

Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum
por: Yan, Libin, et al.
Publicado: (2022)

HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
por: Sun, Guoliang, et al.
Publicado: (2020)

Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
por: Sun, Guoliang, et al.
Publicado: (2023)

Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma
por: Chen, Ke, et al.
Publicado: (2021)

Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer
por: Ding, Beichen, et al.
Publicado: (2019)

CD46 splice variant enhances translation of specific mRNAs linked to an aggressive tumor cell phenotype in bladder cancer
por: Zeng, Jin, et al.
Publicado: (2021)

Genetic alteration of histone lysine methyltransferases and their significance in renal cell carcinoma
por: Yan, Libin, et al.
Publicado: (2019)

Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer
por: Zhang, Yangjun, et al.
Publicado: (2019)

Efficacy and safety of PDE5-Is and α-1 blockers for treating lower ureteric stones or LUTS: a meta-analysis of RCTs
por: Sun, Xifeng, et al.
Publicado: (2018)

Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial–Mesenchymal Transition
por: Sun, Guoliang, et al.
Publicado: (2021)

Corrigendum: Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma via promoting proliferation and epithelial–mesenchymal transition
por: Sun, Guoliang, et al.
Publicado: (2022)

Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
por: Hu, Junhui, et al.
Publicado: (2019)

Regulatory Network of Two Tumor-Suppressive Noncoding RNAs Interferes with the Growth and Metastasis of Renal Cell Carcinoma
por: Zhou, Hui, et al.
Publicado: (2019)

Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
por: Binh, Mai Thanh, et al.
Publicado: (2020)

Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth
por: Kontaki, Haroula, et al.
Publicado: (2021)

Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2
por: Siddique, Abu Bakar, et al.
Publicado: (2022)

Metformin suppresses calcium oxalate crystal-induced kidney injury by promoting Sirt1 and M2 macrophage-mediated anti-inflammatory activation
por: Liu, Haoran, et al.
Publicado: (2023)

Ranunculus ternatus Thunb extract attenuates renal fibrosis of diabetic nephropathy via inhibiting SMYD2
por: Xu, Weiwei, et al.
Publicado: (2022)

Chitooligosaccharides Modulate Glucose-Lipid Metabolism by Suppressing SMYD3 Pathways and Regulating Gut Microflora
por: Wang, Qiutong, et al.
Publicado: (2020)

Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis
por: Liu, Haoran, et al.
Publicado: (2020)

Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum
por: Liu, Haoran, et al.
Publicado: (2022)

XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis-Induced Renal Inflammation and Oxidative Injury via the miR-223/NLRP3 Pathway
por: Lv, Peng, et al.
Publicado: (2021)

miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
por: Yang, Dong, et al.
Publicado: (2017)

MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2
por: Shang, Chao, et al.
Publicado: (2012)

MiR-346 suppresses cell proliferation through SMYD3 dependent approach in hepatocellular carcinoma
por: Zhu, Weiyou, et al.
Publicado: (2017)

Evolutionary History of the Smyd Gene Family in Metazoans: A Framework to Identify the Orthologs of Human Smyd Genes in Drosophila and Other Animal Species
por: Calpena, Eduardo, et al.
Publicado: (2015)

SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells
por: Toghill, Bradley J., et al.
Publicado: (2018)

The Immune Checkpoint Regulator PDL1 is an Independent Prognostic Biomarker for Biochemical Recurrence in Prostate Cancer Patients Following Adjuvant Hormonal Therapy
por: Li, Heng, et al.
Publicado: (2019)

Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma
por: Huang, He-Qing, et al.
Publicado: (2021)

SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis
por: Ye, Xiangli, et al.
Publicado: (2016)

SMYD proteins in immunity: dawning of a new era
por: Doughan, Maysaa, et al.
Publicado: (2016)

SMYD2 glutathionylation contributes to degradation of sarcomeric proteins
por: Munkanatta Godage, Dhanushka N. P., et al.
Publicado: (2018)

Histone methyltransferase SMYD2: ubiquitous regulator of disease
por: Yi, Xin, et al.
Publicado: (2019)

Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
por: Thomenius, Michael J., et al.
Publicado: (2018)

miR‐490‐5p suppresses tumour growth in renal cell carcinoma through targeting PIK3CA
por: Chen, Ke, et al.
Publicado: (2015)

Erratum: MicroRNA-125b Down-Regulation Mediates Endometrial Cancer Invasion by Targeting ERBB2
por: Shang, Chao, et al.
Publicado: (2020)

Epithelial SMYD5 Exaggerates IBD by Down-regulating Mitochondrial Functions via Post-Translational Control of PGC-1α Stability
por: Hou, Yuning, et al.
Publicado: (2022)

OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers
por: Zhang, Yangjun, et al.
Publicado: (2021)

Predictive value of preoperative inflammatory response biomarkers for metabolic syndrome and post-PCNL systemic inflammatory response syndrome in patients with nephrolithiasis
por: Tang, Kun, et al.
Publicado: (2017)

Proteomic and microRNA Transcriptome Analysis revealed the microRNA-SmyD1 network regulation in Skeletal Muscle Fibers performance of Chinese perch
por: Chu, WuYing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o4jv9tjhpndf7bas93jf1sfe9p